Evolving Treatment Strategies for Elderly Leukemia Patients with IDH Mutations

Acute myeloid leukemia (AML) is a debilitating and life-threatening condition, especially for elderly patients who account for over 50% of diagnoses. For over four decades, standard induction therapy with intensive cytotoxic chemotherapy for AML had remained unchanged. However, for most patients, st...

Descripción completa

Detalles Bibliográficos
Autores principales: Buege, Michael J., DiPippo, Adam J., DiNardo, Courtney D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6025071/
https://www.ncbi.nlm.nih.gov/pubmed/29882807
http://dx.doi.org/10.3390/cancers10060187

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6025071/
https://www.ncbi.nlm.nih.gov/pubmed/29882807
http://dx.doi.org/10.3390/cancers10060187

Ejemplares similares